Cargando…
Muscarinic Acetylcholine Receptor M3 Expression and Survival in Human Colorectal Carcinoma—An Unexpected Correlation to Guide Future Treatment?
Muscarinic acetylcholine receptor M3 (M3R) has repeatedly been shown to be prominently expressed in human colorectal cancer (CRC), playing roles in proliferation and cell invasion. Its therapeutic targetability has been suggested in vitro and in animal models. We aimed to investigate the clinical ro...
Autores principales: | Lobbes, Leonard A., Schütze, Marcel A., Droeser, Raoul, Arndt, Marco, Pozios, Ioannis, Lauscher, Johannes C., Hering, Nina A., Weixler, Benjamin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179005/ https://www.ncbi.nlm.nih.gov/pubmed/37175905 http://dx.doi.org/10.3390/ijms24098198 |
Ejemplares similares
-
Blockage of Cholinergic Signaling via Muscarinic Acetylcholine Receptor 3 Inhibits Tumor Growth in Human Colorectal Adenocarcinoma
por: Hering, Nina A., et al.
Publicado: (2021) -
Evaluation of the prognostic relevance of the recommended minimum number of lymph nodes in colorectal cancer—a propensity score analysis
por: Ramser, Michaela, et al.
Publicado: (2021) -
Targeting Interleukin-6/Glycoprotein-130 Signaling by Raloxifene or SC144 Enhances Paclitaxel Efficacy in Pancreatic Cancer
por: Hering, Nina A., et al.
Publicado: (2023) -
The Value of Indocyanine Green Image-Guided Surgery in Patients with Primary Liver Tumors and Liver Metastases
por: Weixler, Benjamin, et al.
Publicado: (2023) -
Standardized digital solution with surgical procedure manager (SPM®)—an opportunity for maximizing patient safety and efficiency in ileostomy reversal?
por: Strobel, Rahel M., et al.
Publicado: (2023)